Royal Bank of Canada
LUMO

Royal Bank of Canada’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Royal Bank of Canada’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed – – 7387
2024
Q3 		$0 Sell
50
-28
-36% -$78 ﹤0.01% 7638
2024
Q2 		$0 Hold
78
– – ﹤0.01% 7666
2024
Q1 		$0 Hold
78
– – ﹤0.01% 7737
2023
Q4 		$0 Sell
78
-39
-33% -$133 ﹤0.01% 7701
2023
Q3 		$0 Sell
117
-59
-34% -$184 ﹤0.01% 7727
2023
Q2 		$0 Buy
176
+126
+252% +$445 ﹤0.01% 7756
2023
Q1 		$0 Hold
50
– – ﹤0.01% 7598
2022
Q4 		$0 Sell
50
-202
-80% -$1.32K ﹤0.01% 7851
2022
Q3 		$2K Sell
252
-161
-39% -$1.34K ﹤0.01% 7087
2022
Q2 		$3K Sell
413
-2
-0.5% -$16 ﹤0.01% 6875
2022
Q1 		$4K Buy
415
+198
+91% +$1.77K ﹤0.01% 7349
2021
Q4 		$2K Buy
217
+4
+2% +$34 ﹤0.01% 7437
2021
Q3 		$2K Sell
213
-38
-15% -$357 ﹤0.01% 7374
2021
Q2 		$3K Hold
251
– – ﹤0.01% 7197
2021
Q1 		$3K Buy
251
+179
+249% +$3.01K ﹤0.01% 7185
2020
Q4 		$3K Buy
72
+34
+89% +$586 ﹤0.01% 6819
2020
Q3 		$1K Sell
38
-18
-32% -$269 ﹤0.01% 6501
2020
Q2 		$1K Sell
56
-141
-72% -$1.68K ﹤0.01% 6505
2020
Q1 		$1K Hold
197
– – ﹤0.01% 6516
2019
Q4 		$5K Sell
197
-17
-8% -$243 ﹤0.01% 6374
2019
Q3 		$3K Buy
214
+23
+12% +$337 ﹤0.01% 6229
2019
Q2 		$3K Buy
191
+5
+3% +$76 ﹤0.01% 6509
2019
Q1 		$3K Buy
186
+75
+68% +$1.12K ﹤0.01% 6458
2018
Q4 		$2K Sell
111
-39
-26% -$687 ﹤0.01% 6483
2018
Q3 		$3K Buy
150
+72
+92% +$2.19K ﹤0.01% 6451
2018
Q2 		$4K Buy
78
+16
+26% +$733 ﹤0.01% 6117
2018
Q1 		$4K Sell
62
-52
-46% -$3.68K ﹤0.01% 6006
2017
Q4 		$8K Sell
114
-196
-63% -$16.2K ﹤0.01% 5947
2017
Q3 		$28K Buy
310
+239
+337% +$18.3K ﹤0.01% 5782
2017
Q2 		$4K Sell
71
-54
-43% -$6.68K ﹤0.01% 6138
2017
Q1 		$27K Buy
125
+15
+14% +$2.14K ﹤0.01% 5478
2016
Q4 		$10K Sell
110
-123
-53% -$13.9K ﹤0.01% 6093
2016
Q3 		$32K Sell
233
-30
-11% -$2.98K ﹤0.01% 5365
2016
Q2 		$27K Sell
263
-51
-16% -$6.32K ﹤0.01% 5384
2016
Q1 		$52K Sell
314
-238
-43% -$48.2K ﹤0.01% 5110
2015
Q4 		$181K Buy
552
+387
+235% +$126K ﹤0.01% 4587
2015
Q3 		$53K Buy
165
+80
+94% +$35.1K ﹤0.01% 5099
2015
Q2 		$34K Buy
85
+4
+5% +$1.7K ﹤0.01% 5430
2015
Q1 		$40K Sell
81
-138
-63% -$53.5K ﹤0.01% 5078
2014
Q4 		$79K Sell
219
-4,523
-95% -$1.35M ﹤0.01% 4853
2014
Q3 		$914K Sell
4,742
-355
-7% -$78K ﹤0.01% 2916
2014
Q2 		$1.22M Buy
5,097
+5,066
+16,342% +$1.03M ﹤0.01% 2668
2014
Q1 		$8K Sell
31
-150
-83% -$45.9K ﹤0.01% 5491
2013
Q4 		$36K Buy
181
+43
+31% +$7.65K ﹤0.01% 5034
2013
Q3 		$23K Sell
138
-507
-79% -$81.6K ﹤0.01% 5122
2013
Q2 		$114K Buy
+645
New +$91.3K ﹤0.01% 4238

Royal Bank of Canada's LUMO Position: Q4 2024 in Review

Royal Bank of Canada sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 50 shares.

Royal Bank of Canada first reported a position in LUMO in Q2 2013 and held it in 46 quarters. The position peaked at $1.22M in Q2 2014. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Royal Bank of Canada reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 50 Lumos Pharma, Inc. Common Stock shares in Q4 2024.
  • Royal Bank of Canada first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 46 quarters.
  • Royal Bank of Canada's Lumos Pharma, Inc. Common Stock position peaked at $1.22M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.